Latest Breaking News On - Lance baldo - Page 4 : comparemela.com

Freenome, working with Oracle Cerner network, launches multiomics oncology study

The precision medicine initiative will use real-world data from the Learning Health Network for clinical validation and refinement of cancer risk prediction models.

United statesTim sandersonCerner envizaLance baldoRiley ennisChristy dueckElligo health researchOracle cerner learning health networkHealth networkDuke clinical research instituteSanderson studyOracle cernerLearning health networkFrancisco based freenome

Life sciences and health tech news roundup: AIlen Institute s new CEO, AI2 s incubator, and more

Life sciences and health tech news roundup: AIlen Institute s new CEO, AI2 s incubator, and more
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

University of washingtonUnited statesNoord hollandFred hutchLance baldoPaul allenJonathan harperPhil greenbergHeather greenleeTodd bishopRui costaYves leurquinAllen instituteAlpine immune sciencesNational institutes of healthUs national institutes of health

Tech Moves: Adaptive Biotechnologies chief medical officer resigns; Athira Pharma s new hires

Tech Moves: Adaptive Biotechnologies chief medical officer resigns; Athira Pharma s new hires
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Lana gloukhovaAthira pharmaRobert renningerJosh panLance baldoSharon benzenoSimon daggettAdaptive photoSouth san franciscoTycho petersonNitin soodSouth san francisco based genentechBioniz therapeuticsLeen kawas

Adaptive Biotechnologies Makes Progress Toward T-Cell Assay for Inflammatory Bowel Disease

The Seattle-based company recently published immune repertoire data showing the potential of T-cell receptor profiling in IBD diagnostics.

France generalLance baldoColitis organisationDrug administration emergency use authorizationAdaptive biotechnologiesEuropean crohnMatthieu allezHospital saint louisT detect lyme

Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD Testing

Analysis of the MASTER trial (Abstract 481) showed clonoSEQ’s ability to measure deep and durable responses and permit treatment discontinuation in multiple myeloma patients Data in more than 30 abstracts

United statesCarrie mendivilLance baldoKarina calzadillaErica schmittExchange commissionAmerican society of hematologyKoch industriesAdaptive biotechnologies corporation nasdaqGilmartin groupBiotechnologies corporationAmerican societyAnnual meetingAutologous transplantationAdapted consolidationFinal primary endpoint analysis